Quick Answer
Q32 Bio Inc. reported Stockholders Equity of $42.01 million for fiscal year 2025.
Q32 Bio Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $42.01M | +640.3% |
| 2024 | $5.67M | +103.1% |
| 2023 | -$182.92M | -39.9% |
| 2022 | -$130.71M | -177.0% |
| 2021 | $169.65M | -13.4% |
| 2020 | $196.00M | -24.2% |
| 2019 | $258.51M | +31.7% |
| 2018 | $196.35M | +597.7% |
| 2017 | -$39.45M | -298.8% |
| 2016 | -$9.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$18.45M | -200.8% | -50.8% |
| June 30, 2025 | -$12.23M | -136.5% | -405.9% |
| May 31, 2025 | $4.00M | — | +199.7% |
| March 31, 2025 | -$4.01M | -108.2% | -170.7% |
| December 31, 2024 | $5.67M | +103.1% | -69.0% |
| September 30, 2024 | $18.30M | +111.7% | -45.4% |
| June 30, 2024 | $33.51M | +123.5% | -31.3% |
| March 31, 2024 | $48.77M | +135.5% | +126.7% |
- Q32 Bio Inc. showed an increase of +640.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Q32 Bio Inc.’s stockholders equity has grown by 524.7% (from -$9.89 million to $42.01 million).
- The most recent figure is from Q32 Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: